Skip to main content
MNKD logo

MNKD · Mannkind Corp

Track MNKD — free
$4.04 -0.02 (-0.49%)
Market Cap
$1.31B
Shares
321.54M

MNKD metrics

73 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$4.06
Market cap
$1.31B

Price action

19 metrics
Price change (1W)
+2.8%
Price change (30D)
+3.3%
Price change (3M)
+19.4%
Price change (6M)
+55.6%
Price change (YTD)
-28.4%
Price change (1Y)
-24.0%
Trailing year
Price change (5Y)
-14.0%
52-week high
$6.21
52-week low
$2.28
Change from 52-week high
-34.6%
Change from 52-week low
+78.1%
Annualized volatility
68.2%
Beta
1.1
RSI (14D)
51.6
Price vs SMA 50
+0.4%
Price vs SMA 200
-2.3%
Avg volume (3M)
4.49M
Relative volume
0.6
Average dollar volume
$17.96M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
321.54M

Valuation

12 metrics
P / E (TTM)
Trailing earnings
PEG ratio
EV / revenue
EV / EBITDA
EV / EBIT
P / sales
3.3×
reciprocal yield 30.2%
P / book
FCF yield
-1.4%
TTM · current market cap
Buyback yield
P / FCF
P / operating cash flow
Earnings yield
-3.3%

Historical valuation

8 metrics
P / E historical average (3Y)
82.2×
reciprocal yield 1.2%
P / E historical average (5Y)
82.2×
reciprocal yield 1.2%
EV / revenue historical average (3Y)
5.2×
reciprocal yield 19.3%
EV / revenue historical average (5Y)
8.5×
reciprocal yield 11.8%
EV / EBIT historical average (3Y)
52.3×
reciprocal yield 1.9%
EV / EBIT historical average (5Y)
52.3×
reciprocal yield 1.9%
EV / EBITDA historical average (3Y)
28.9×
reciprocal yield 3.5%
EV / EBITDA historical average (5Y)
28.9×
reciprocal yield 3.5%

Dividends & buybacks

7 metrics
Dividend yield
Trailing 12 months
Payout ratio
Shareholder yield
Dividend / share (TTM)
Dividend growth YoY
Dividend growth streak
Last ex-dividend

Earnings calendar

2 metrics
Next earnings
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
89.8%
Operating margin
2.3%
Trailing 12 months
Net margin
-11.1%
Gross profit (TTM)
Operating profit (TTM)
$9.19M
Net income (TTM)
−$43.61M
Trailing 12 months
Diluted EPS (TTM)
$-0.13
FCF margin
-4.6%
Effective tax rate

Per share

11 metrics
Revenue per diluted share (TTM)
Gross profit per diluted share (TTM)
Operating profit per diluted share (TTM)
EBITDA per diluted share (TTM)
Net income per diluted share (TTM)
Operating cash flow per diluted share (TTM)
Free cash flow per diluted share (TTM)
Capital expenditures per diluted share (TTM)
R&D per diluted share (TTM)
Stock compensation per diluted share (TTM)
Book value per share
$-1.45

Growth

11 metrics
Revenue growth YoY
+42.9%
Year over year
Net income growth YoY
-2,949.1%
Revenue (TTM)
$393.63M
Trailing 12 months
EPS growth YoY
-80.0%
Shares change YoY
-0.7%
Year over year · fewer shares
Revenue CAGR (3Y)
+51.8%
Revenue CAGR (5Y)
+39.9%
EPS CAGR (3Y)
EPS CAGR (5Y)
FCF CAGR (3Y)
FCF CAGR (5Y)

Quality

14 metrics
Return on equity
Return on assets
-6.0%
Debt / equity
Current ratio
1.7
EBITDA (TTM)
$30.06M
Free cash flow (TTM)
−$18.14M
Quick ratio
1.4
Interest coverage
0.3
Net debt / EBITDA
Return on invested capital
Trailing 12 months
Net cash
Latest balance sheet
Cash & equivalents
$52.93M
Total assets
$732.30M
Total debt

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$8.05M
Capital expenditures (TTM)
$10.08M
R&D (TTM)
$76.88M
SG&A (TTM)
$199.89M
Stock compensation (TTM)
$27.97M
R&D / revenue
19.5%
Stock compensation / revenue
7.1%

Ownership (13F)

3 metrics
13F filers
259
13F filer change QoQ
+5
Institutional ownership
57.4%

Short interest

3 metrics
Short interest
8.9%
Latest settlement · 5.6 days to cover
Days to cover
5.6d
Short-squeeze score
73 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$469,278
Insider-sentiment score

Risk flags

1 metrics
Going concern
Key facts CIK 899460 CUSIP 56400P706 13F (30d) 160 filings 160 filers Visit website Investor relations